Certus
Certus is Lapatinib, an oral dual HER2/EGFR tyrosine kinase inhibitor. It is indicated for HER2-positive breast cancer and works by blocking intracellular HER2 and EGFR signaling pathways.
Features
| Product Name | Certus |
| Generic Name | Lapatinib |
| Formulation | Tablet |
| Available Pack Size | 1X35's |
| Available Strength | 250MG |